Gibson Dunn Adds FDA and Health Care Partner Katlin McKelvie to D.C. Office

January 29, 2024

Gibson, Dunn & Crutcher LLP is pleased to announce that Katlin McKelvie has joined the firm as a partner in the Washington, D.C. office, where she will practice in the firm’s FDA and Health Care Practice Group. Katlin was previously Deputy General Counsel for the U.S. Department of Health and Human Services and served in senior roles at the U.S. Food and Drug Administration and on the U.S. Senate HELP Committee.

“We are excited to welcome Katlin to the firm,” said Gustav Eyler, Co-Chair of Gibson Dunn’s FDA and Health Care Practice Group. “With her significant government experience handling matters across FDA-regulated product categories – including food, drugs, medical devices, and cosmetics – Katlin is an excellent addition to Gibson Dunn’s leading regulatory, litigation, and policy team. Her versatility to handle issues across the FDA-regulated spectrum will be an exceptional complement to our capabilities and an invaluable asset to our clients.”

“Through her prior senior posts at HHS, FDA, and the Senate, Katlin has seen the FDA and regulated-product issues from all angles,” said Greta Williams, Co-Partner in Charge of Gibson Dunn’s Washington, D.C. office. “Her background and unique experiences, including related to the life sciences, health care, and technology spaces, will help our clients navigate the complex landscape of laws, regulations, and policies affecting those industries.”

“I am thrilled to be part of the talented team at Gibson Dunn,” said Katlin. “The firm’s dedication to providing world-class client service, along with a commitment to staying at the cutting edge of regulatory and policy developments, offers an opportunity to help clients across FDA-regulated sectors.”

Gibson Dunn has award-winning practices dedicated to helping life sciences, health care, and consumer product companies. The firm’s team includes senior officials from the U.S. Department of Justice, Federal Trade Commission, and other agencies at the forefront of consumer protection, competition, white collar investigations, transactional, and policy areas. Those former officials include several who recently joined the firm, including Gus Eyler, who served as Director of the Department of Justice’s Consumer Protection Branch, Svetlana Gans, who served as Chief of Staff at the Federal Trade Commission, and former federal judges Gregg Costa and George Hazel.

About Katlin McKelvie

Katlin has extensive experience spanning all FDA product categories, with a particular focus on drug regulatory matters. At Gibson Dunn, Katlin will provide regulatory advice to companies engaged in manufacturing, distributing, marketing and selling FDA-regulated products. She will also advise FDA-regulated companies on issues related to enforcement, compliance, and litigation, corporate transactions, as well as legislative policymaking and agency regulatory strategy.

Before joining the firm, Katlin served as Deputy General Counsel at the Department of Health and Human Services. Prior, she served as Deputy Health Policy Director and Senior FDA Counsel to the U.S. Senate Committee on Health, Education, Labor and Pensions for Chair Patty Murray. During her career, she also served as Associate Chief Counsel for Drugs in FDA’s Office of the Chief Counsel and as Regulatory Counsel in the Office of Prescription Drug Promotion in FDA’s Center for Drug Evaluation and Research.

Katlin graduated cum laude from Georgetown University Law Center in 2001, where she served as Executive Editor of The Georgetown Law Journal. She clerked for Judge Douglas P. Woodlock in the U.S. District Court for the District of Massachusetts.